Keyphrases
Breast Cancer
100%
Oncoprotein
100%
Circulating Levels
100%
Her2neu
100%
Extracellular Domain
72%
Metastatic Breast Cancer
45%
Tissue Testing
18%
Estrogen Receptor
9%
Membrane Receptors
9%
Receptor-interacting Protein Kinase 1 (RIPK1)
9%
Overexpressing
9%
Breast Cancer Cells
9%
Enzyme-linked Immunosorbent Assay (ELISA)
9%
Epithelial Cells
9%
Treatment Regimen
9%
After Surgery
9%
Women with Breast Cancer
9%
Cancer Therapy
9%
Clinical Diagnosis
9%
Patients with Breast Cancer
9%
Clinical Course
9%
Breast Tumor
9%
Disease Course
9%
Hormone Therapy
9%
C-erbB-2
9%
Primary Breast Cancer
9%
Neu Oncogene
9%
Breast Cancer Recurrence
9%
Event Monitoring
9%
Assay Method
9%
Time Assessment
9%
Time Event
9%
Medicine and Dentistry
Breast Cancer
100%
Epidermal Growth Factor Receptor 2
100%
Metastatic Breast Cancer
71%
Diseases
28%
Neoplasm
14%
Prevalence
14%
Epithelial Cell
14%
Cancer Cell
14%
Recurrent Disease
14%
Cancer Therapy
14%
Hormone Therapy
14%
Estrogen Receptor
14%
Enzyme Linked Immunosorbent Assay
14%
Disease Course
14%
Receptor Protein
14%
Oncogene Neu
14%
Nursing and Health Professions
Breast Cancer
100%
Epidermal Growth Factor Receptor 2
100%
Metastatic Breast Cancer
71%
Diseases
28%
Prevalence
14%
Neoplasm
14%
Cancer Therapy
14%
Disease Course
14%
Hormonal Therapy
14%
Enzyme Linked Immunosorbent Assay
14%
Recurrent Disease
14%
Estrogen Receptor
14%
Biochemistry, Genetics and Molecular Biology
HER2/neu
100%
Estrogen Receptor
9%
Transmembrane Receptors
9%
Enzyme
9%
Cancer Cell
9%
Prevalence
9%
Oncogene Neu
9%